Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Masahiro Takeuchi, Sc.D.

Title
Institution
Department
Address

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Takeuchi M, Mitsuyoshi M, Yoshida K, Onoda M, Iwamura M, Furutani A, Kawano K, Katoh T. The Lymphocyte-to-monocyte Ratio Is an Independent Prognostic Indicator in Pancreatic Head Cancer that Correlates With Obstructive Jaundice. Anticancer Res. 2020 Jun; 40(6):3371-3377. PMID: 32487633.
    Citations:    
  2. Yamano T, Tomita N, Sato T, Hayakawa K, Kamikonya N, Matoba S, Uki A, Baba H, Oya N, Hasegawa H, Shigematsu N, Hiraoka M, Shimada M, Noda M, Sakai Y, Sato H, Saegusa M, Takeuchi M, Oguchi M, Oya M, Watanabe M. Influence of chemoradiotherapy on nutritional status in locally advanced rectal cancer: Prospective multicenter study. Nutrition. 2020 Mar 19; 77:110807. PMID: 32402940.
    Citations:    
  3. Nakao S, Arai Y, Tasaki M, Yamashita M, Murakami R, Kawase T, Amino N, Nakatake M, Kurosaki H, Mori M, Takeuchi M, Nakamura T. Intratumoral expression of IL-7 and IL-12 using an oncolytic virus increases systemic sensitivity to immune checkpoint blockade. Sci Transl Med. 2020 01 15; 12(526). PMID: 31941828.
    Citations:    
  4. Tanaka H, Kaneko N, Sakagami H, Matsuya T, Hiramoto M, Yamanaka Y, Mori M, Koshio H, Hirano M, Takeuchi M. Naquotinib exerts antitumor activity in activated B-cell-like diffuse large B-cell lymphoma. Leuk Res. 2020 01; 88:106286. PMID: 31865062.
    Citations:    
  5. Nagai Y, Tsukamoto S, Hino Y, Isshiki Y, Yamazaki M, Izumi S, Mishina T, Oshima-Hasegawa N, Mitsukawa S, Takeda Y, Mimura N, Ohwada C, Takeuchi M, Iseki T, Nakaseko C, Sakaida E. Remarkable donor-derived T cell lymphocytosis before engraftment of a bone marrow transplant for acute lymphoblastic leukemia. Leuk Lymphoma. 2020 01; 61(1):221-224. PMID: 31486335.
    Citations:    
  6. Takaishi K, Takeuchi M, Tsukamoto S, Takayama N, Oshima M, Kimura K, Isshiki Y, Kayamori K, Hino Y, Oshima-Hasegawa N, Mitsukawa S, Takeda Y, Mimura N, Ohwada C, Iseki T, Nakamura S, Eto K, Iwama A, Yokote K, Nakaseko C, Sakaida E. Suppressive effects of anagrelide on cell cycle progression and the maturation of megakaryocyte progenitor cell lines in human induced pluripotent stem cells. Haematologica. 2020 May; 105(5):e216-e220. PMID: 31488559.
    Citations:    
  7. Nakamura A, Ohwada C, Takeuchi M, Takeda Y, Tsukamoto S, Mimura N, Nagisa OH, Sugita Y, Tanaka H, Wakita H, Aotsuka N, Matsue K, Yokote K, Ohara O, Nakaseko C, Sakaida E. Detection of MYD88 L265P mutation by next-generation deep sequencing in peripheral blood mononuclear cells of Waldenström's macroglobulinemia and IgM monoclonal gammopathy of undetermined significance. PLoS One. 2019; 14(9):e0221941. PMID: 31483817.
    Citations:    
  8. Yamazaki M, Nakaseko C, Takeuchi M, Ozawa S, Ishizuka Y, Hatanaka Y, Oshima-Hasegawa N, Muto T, Tsukamoto S, Mitsukawa S, Ohwada C, Takeda Y, Mimura N, Iseki T, Fukazawa M, Sakaida E. Myeloid/Lymphoid Neoplasm with PDGFRB Rearrangement with t (5;10) (q33;q22) Harboring a Novel Breakpoint of the CCDC6-PDGFRB Fusion Gene. Intern Med. 2019 Dec 01; 58(23):3449-3453. PMID: 31327842.
    Citations:    
  9. Takaishi K, Tsukamoto S, Ohwada C, Takeuchi M, Kawasaki Y, Nagai Y, Mishina T, Yamazaki M, Isshiki Y, Kayamori K, Kimura K, Hino Y, Oshima-Hasegawa N, Mitsukawa S, Takeda Y, Mimura N, Iseki T, Nakaseko C, Sakaida E. Low incidence of thromboembolism in multiple myeloma patients receiving immunomodulatory drugs; a retrospective single-institution analysis. J Thromb Thrombolysis. 2019 Jul; 48(1):141-148. PMID: 30673940.
    Citations:    Fields:    
  10. Kanba S, Murasaki M, Koyama T, Takeuchi M, Shimizu Y, Arita E, Kuroishi K, Takeuchi M, Kamei S. Long-term mood/antidepressant effects of quetiapine extended-release formulation: an open-label, non-controlled extension study in Japanese patients with bipolar depression. BMC Psychiatry. 2019 06 26; 19(1):198. PMID: 31242884.
    Citations:    
  11. Takeuchi M, Ajani JA, Fang X, Pfeiffer P, Takeuchi M, van Laarhoven HWM. Meta-Enrichment Analyses to Identify Advanced Gastric Cancer Patients Who Achieve a Higher Response to S-1/Cisplatin. Cancers (Basel). 2019 06 21; 11(6). PMID: 31234436.
    Citations:    
  12. Shimizu R, Takeuchi M, Sakaida E, Ohwada C, Toyosaki M, Machida S, Onizuka M, Shono K, Onoda M, Saito T, Yano S, Tanaka M, Fujisawa S, Mori T, Usuki K, Takahashi S, Kanamori H, Nakaseko C, Okamoto S. Efficacy and safety of oral deferasirox treatment for transfusional iron overload in pure red cell aplasia patients after allogeneic stem cell transplantation. Ann Hematol. 2019 Jul; 98(7):1781-1783. PMID: 31119366.
    Citations:    
  13. Tanaka H, Sakagami H, Kaneko N, Konagai S, Yamamoto H, Matsuya T, Yuri M, Yamanaka Y, Mori M, Takeuchi M, Koshio H, Hirano M, Kuromitsu S. Mutant-Selective Irreversible EGFR Inhibitor, Naquotinib, Inhibits Tumor Growth in NSCLC Models with EGFR-Activating Mutations, T790M Mutation, and AXL Overexpression. Mol Cancer Ther. 2019 08; 18(8):1366-1373. PMID: 31092564.
    Citations:    
  14. Ueno Y, Mori M, Kamiyama Y, Saito R, Kaneko N, Isshiki E, Kuromitsu S, Takeuchi M. Evaluation of gilteritinib in combination with chemotherapy in preclinical models of FLT3-ITD+ acute myeloid leukemia. Oncotarget. 2019 Apr 02; 10(26):2530-2545. PMID: 31069015.
    Citations:    
  15. Yoshida K, Kodera Y, Kochi M, Ichikawa W, Kakeji Y, Sano T, Nagao N, Takahashi M, Takagane A, Watanabe T, Kaji M, Okitsu H, Nomura T, Matsui T, Yoshikawa T, Matsuyama J, Yamada M, Ito S, Takeuchi M, Fujii M. Addition of Docetaxel to Oral Fluoropyrimidine Improves Efficacy in Patients With Stage III Gastric Cancer: Interim Analysis of JACCRO GC-07, a Randomized Controlled Trial. J Clin Oncol. 2019 05 20; 37(15):1296-1304. PMID: 30925125.
    Citations:    
  16. Sai K, Yoshida A, Hanatani T, Imatoh T, Takeuchi M, Narukawa M, Watanabe H, Uyama Y, Saito Y. Population/regional differences in efficacy of 3 drug categories (antidiabetic, respiratory and psychotropic agents) among East Asians: A retrospective study based on multiregional clinical trials. Br J Clin Pharmacol. 2019 06; 85(6):1270-1282. PMID: 30735569.
    Citations:    
  17. Hamanaka S, Nakagawa T, Ota S, Iida M, Ohta Y, Isshiki Y, Kasamatsu S, Ishigami H, Taida T, Okimoto K, Saito K, Maruoka D, Matsumura T, Ohwada C, Takeuchi M, Sakaida E, Arai M, Katsuno T, Nakaseko C, Nakatani Y, Kato N. Immunomodulator-associated Epstein-Barr virus-positive mucocutaneous ulcer in a patient with refractory Crohn's disease. Clin J Gastroenterol. 2019 Aug; 12(4):330-335. PMID: 30903514.
    Citations:    
  18. Kimura K, Tsukamoto S, Takaishi K, Isshiki Y, Kayamori K, Hino Y, Ohshima-Hasegawa N, Mitsukawa S, Takeda Y, Mimura N, Takeuchi M, Ohwada C, Iseki T, Nakaseko C, Sakaida E. T315I mutation with lymphoblasts in a newly diagnosed patient with chronic-phase chronic myeloid leukemia. Leuk Lymphoma. 2019 06; 60(6):1591-1594. PMID: 31161870.
    Citations:    
  19. Nagao Y, Mimura N, Takeda J, Yoshida K, Shiozawa Y, Oshima M, Aoyama K, Saraya A, Koide S, Rizq O, Hasegawa Y, Shiraishi Y, Chiba K, Tanaka H, Nishijima D, Isshiki Y, Kayamori K, Kawajiri-Manako C, Oshima-Hasegawa N, Tsukamoto S, Mitsukawa S, Takeda Y, Ohwada C, Takeuchi M, Iseki T, Misawa S, Miyano S, Ohara O, Yokote K, Sakaida E, Kuwabara S, Sanada M, Iwama A, Ogawa S, Nakaseko C. Genetic and transcriptional landscape of plasma cells in POEMS syndrome. Leukemia. 2019 07; 33(7):1723-1735. PMID: 30635632.
    Citations:    Fields:    
  20. Yamanouchi K, Takeuchi M, Arima H, Tsujiguchi T. Development of a method to extract protozoan DNA from black soil. Parasite Epidemiol Control. 2019 Feb; 4:e00081. PMID: 30662966.
    Citations:    
  21. Itoh H, Komuro I, Takeuchi M, Akasaka T, Daida H, Egashira Y, Fujita H, Higaki J, Hirata KI, Ishibashi S, Isshiki T, Ito S, Kashiwagi A, Kato S, Kitagawa K, Kitakaze M, Kitazono T, Kurabayashi M, Miyauchi K, Murakami T, Murohara T, Node K, Ogawa S, Saito Y, Seino Y, Shigeeda T, Shindo S, Sugawara M, Sugiyama S, Terauchi Y, Tsutsui H, Ueshima K, Utsunomiya K, Yamagishi M, Yamazaki T, Yo S, Yokote K, Yoshida K, Yoshimura M, Yoshimura N, Nakao K, Nagai R. Achieving LDL cholesterol target levels <1.81 mmol/L may provide extra cardiovascular protection in patients at high risk: Exploratory analysis of the Standard Versus Intensive Statin Therapy for Patients with Hypercholesterolaemia and Diabetic Retinopathy study. Diabetes Obes Metab. 2019 04; 21(4):791-800. PMID: 30393955.
    Citations:    Fields:    
  22. Ioka T, Ueno M, Ueno H, Park JO, Chang HM, Sasahira N, Kanai M, Chung IJ, Ikeda M, Nakamori S, Mizuno N, Omuro Y, Yamaguchi T, Hara H, Sugimori K, Furuse J, Maguchi H, Furukawa M, Fukuzawa K, Kim JS, Yukisawa S, Takeuchi M, Okusaka T, Boku N, Hyodo I. TAS-118 (S-1 plus leucovorin) versus S-1 in patients with gemcitabine-refractory advanced pancreatic cancer: a randomised, open-label, phase 3 study (GRAPE trial). Eur J Cancer. 2019 01; 106:78-88. PMID: 30471651.
    Citations:    Fields:    
  23. Niho S, Ikeda N, Michimae H, Suzuki K, Sakai H, Kaburagi T, Yoshiya K, Minato K, Kato T, Okamoto H, Seto T, Hosomi Y, Shimizu K, Saito H, Tsuchida M, Kunitoh H, Tsuboi M, Takeuchi M, Watanabe K. Overall Survival Results of the Feasibility Study of Adjuvant Chemotherapy With Docetaxel Plus Cisplatin Followed by Long-term Single-agent Administration of S-1 in Patients With Completely Resected Non-Small Cell Lung Cancer: Thoracic Oncology Research Group (TORG) 0809. Am J Clin Oncol. 2018 Nov; 41(11):1113-1117. PMID: 29521649.
    Citations:    Fields:    
  24. Murasaki M, Koyama T, Kanba S, Takeuchi M, Shimizu Y, Arita E, Kuroishi K, Takeuchi M, Kamei S. Correction to: Multi-center, randomized, double-blind, placebocontrolled study of quetiapine extended-release formulation in Japanese patients with bipolar depression. Psychopharmacology (Berl). 2018 10; 235(10):3079-3080. PMID: 30221314.
    Citations:    Fields:    
  25. Kawajiri-Manako C, Mimura N, Fukuyo M, Namba H, Rahmutulla B, Nagao Y, Togasaki E, Shimizu R, Oshima-Hasegawa N, Tsukamoto S, Mitsukawa S, Takeda Y, Ohwada C, Takeuchi M, Iseki T, Misawa S, Yokote K, Tsuiji M, Kuwabara S, Sakaida E, Kaneda A, Nakaseko C. Clonal immunoglobulin ? light-chain gene rearrangements detected by next generation sequencing in POEMS syndrome. Am J Hematol. 2018 09; 93(9):1161-1168. PMID: 30015379.
    Citations:    Fields:    
  26. Aoki Y, Ochiai K, Lim S, Aoki D, Kamiura S, Lin H, Katsumata N, Cha SD, Kim JH, Kim BG, Hirashima Y, Fujiwara K, Kim YT, Kim SM, Chung HH, Chang TC, Kamura T, Takizawa K, Takeuchi M, Kang SB. Phase III study of cisplatin with or without S-1 in patients with stage IVB, recurrent, or persistent cervical cancer. Br J Cancer. 2018 08; 119(5):530-537. PMID: 30072745.
    Citations:    Fields:    
  27. Murasaki M, Koyama T, Kanba S, Takeuchi M, Shimizu Y, Arita E, Kuroishi K, Takeuchi M, Kamei S. Multi-center, randomized, double-blind, placebo-controlled study of quetiapine extended-release formulation in Japanese patients with bipolar depression. Psychopharmacology (Berl). 2018 Oct; 235(10):2859-2869. PMID: 30069587.
    Citations:    Fields:    Translation:Humans
  28. Claggett B, Tian L, McCaw ZR, Takeuchi M, Wei LJ. Sex as a predictor of response to cancer immunotherapy. Lancet Oncol. 2018 08; 19(8):e377. PMID: 30102227.
    Citations:    Fields:    
  29. Satake H, Sunakawa Y, Miyamoto Y, Nakamura M, Nakayama H, Shiozawa M, Makiyama A, Kobayashi K, Kubota Y, Mori M, Kotaka M, Takagane A, Gotoh M, Takeuchi M, Fujii M, Ichikawa W, Sekikawa T. Correction: A phase II trial of 1st-line modified-FOLFOXIRI plus bevacizumab treatment for metastatic colorectal cancer harboring RAS mutation: JACCRO CC-11. Oncotarget. 2018 07 06; 9(52):30023. PMID: 30042830.
    Citations:    Fields:    
  30. Takaishi K, Muto T, Mimura N, Takiguchi J, Nagao Y, Oshima-Hasegawa N, Tsukamoto S, Takeda Y, Mitsukawa S, Takeuchi M, Ohwada C, Ota S, Iseki T, Nakaseko C, Sakaida E. Long-term complete remission following tandem autologous stem cell transplantation and consolidative radiotherapy for refractory mediastinal gray-zone lymphoma. Int J Hematol. 2018 Oct; 108(4):452-455. PMID: 29786758.
    Citations:    Fields:    Translation:Humans
  31. Tsuru M, Ono A, Umeyama H, Takeuchi M, Nagata K. Ubiquitin-dependent proteolysis of CXCL7 leads to posterior longitudinal ligament ossification. PLoS One. 2018; 13(5):e0196204. PMID: 29782494.
    Citations:    Fields:    Translation:HumansAnimalsCells
  32. Kimura Y, Fujii M, Masuishi T, Nishikawa K, Kunisaki C, Matsusaka S, Segawa Y, Nakamura M, Sasaki K, Nagao N, Hatachi Y, Yuasa Y, Asami S, Takeuchi M, Furukawa H, Nakajima T. Correction to: Multicenter phase II study of trastuzumab plus S-1 alone in elderly patients with HER2-positive advanced gastric cancer (JACCRO GC-06). Gastric Cancer. 2018 05; 21(3):428. PMID: 29234896.
    Citations:    Fields:    
  33. Horiguchi M, Cronin AM, Takeuchi M, Uno H. A flexible and coherent test/estimation procedure based on restricted mean survival times for censored time-to-event data in randomized clinical trials. Stat Med. 2018 07 10; 37(15):2307-2320. PMID: 29682762.
    Citations:    Fields:    
  34. Satake H, Sunakawa Y, Miyamoto Y, Nakamura M, Nakayama H, Shiozawa M, Makiyama A, Kobayashi K, Kubota Y, Mori M, Kotaka M, Takagane A, Gotoh M, Takeuchi M, Fujii M, Ichikawa W, Sekikawa T. A phase II trial of 1st-line modified-FOLFOXIRI plus bevacizumab treatment for metastatic colorectal cancer harboring RAS mutation: JACCRO CC-11. Oncotarget. 2018 04 10; 9(27):18811-18820. PMID: 29721163.
    Citations:    Fields:    
  35. Itoh H, Komuro I, Takeuchi M, Akasaka T, Daida H, Egashira Y, Fujita H, Higaki J, Hirata KI, Ishibashi S, Isshiki T, Ito S, Kashiwagi A, Kato S, Kitagawa K, Kitakaze M, Kitazono T, Kurabayashi M, Miyauchi K, Murakami T, Murohara T, Node K, Ogawa S, Saito Y, Seino Y, Shigeeda T, Shindo S, Sugawara M, Sugiyama S, Terauchi Y, Tsutsui H, Ueshima K, Utsunomiya K, Yamagishi M, Yamazaki T, Yo S, Yokote K, Yoshida K, Yoshimura M, Yoshimura N, Nakao K, Nagai R. Intensive Treat-to-Target Statin Therapy in High-Risk Japanese Patients With Hypercholesterolemia and Diabetic Retinopathy: Report of a Randomized Study. Diabetes Care. 2018 06; 41(6):1275-1284. PMID: 29626074.
    Citations:    Fields:    Translation:Humans
  36. Takeuchi M, Sakamoto Y, Noguchi H, Yamada S, Hirata K. Tubulocystic Carcinoma of the Bile Duct. Case Reports Hepatol. 2018; 2018:2304610. PMID: 29805823.
    Citations:    
  37. Imanishi N, Hirai A, Yoneda K, Shimajiri S, Kuwata T, Tashima Y, Takeuchi M, Iwai Y, Ichiki Y, Tanaka F. Programmed death-ligand 1 (PD-L1) expression in pleomorphic carcinoma of the lung. J Surg Oncol. 2018 06; 117(7):1563-1569. PMID: 29601633.
    Citations: 1     Fields:    Translation:Humans
  38. Ohwada C, Sakaida E, Kawajiri-Manako C, Nagao Y, Oshima-Hasegawa N, Togasaki E, Muto T, Tsukamoto S, Mitsukawa S, Takeda Y, Mimura N, Takeuchi M, Shimizu N, Misawa S, Iseki T, Kuwabara S, Nakaseko C. Long-term evaluation of physical improvement and survival of autologous stem cell transplantation in POEMS syndrome. Blood. 2018 05 10; 131(19):2173-2176. PMID: 29599110.
    Citations:    Fields:    
  39. Satake H, Tsuji A, Nakamura M, Ogawa M, Kotake T, Hatachi Y, Yasui H, Takagane A, Okita Y, Nakamura K, Onikubo T, Takeuchi M, Fujii M. Phase I study of primary treatment with 5-FU, oxaliplatin, irinotecan, levofolinate, and panitumumab combination chemotherapy in patients with advanced/recurrent colorectal cancer involving the wild-type RAS gene: the JACCRO CC-14 study. Int J Clin Oncol. 2018 Jun; 23(3):490-496. PMID: 29464396.
    Citations:    Fields:    Translation:HumansCTClinical Trials
  40. Takeuchi M, Doi T, Obayashi K, Hirai A, Yoneda K, Tanaka F, Iwai Y. Soluble PD-L1 with PD-1-binding capacity exists in the plasma of patients with non-small cell lung cancer. Immunol Lett. 2018 04; 196:155-160. PMID: 29366663.
    Citations:    
  41. Togasaki E, Shimizu N, Nagao Y, Kawajiri-Manako C, Shimizu R, Oshima-Hasegawa N, Muto T, Tsukamoto S, Mitsukawa S, Takeda Y, Mimura N, Ohwada C, Takeuchi M, Sakaida E, Iseki T, Yoshitomi H, Ohtsuka M, Miyazaki M, Nakaseko C. Long-term efficacy of partial splenic embolization for the treatment of steroid-resistant chronic immune thrombocytopenia. Ann Hematol. 2018 Apr; 97(4):655-662. PMID: 29332223.
    Citations:    Fields:    Translation:Humans
  42. Tachibana T, Kanda J, Machida S, Saito T, Tanaka M, Najima Y, Koyama S, Miyazaki T, Yamamoto E, Takeuchi M, Morita S, Kanda Y, Kanamori H, Okamoto S. Deferasirox for the treatment of iron overload after allogeneic hematopoietic cell transplantation: multicenter phase I study (KSGCT1302). Int J Hematol. 2018 May; 107(5):578-585. PMID: 29305770.
    Citations:    Fields:    Translation:HumansCTClinical Trials
  43. Izumi S, Kimura K, Takeda Y, Tsukamoto S, Yamazaki M, Mishina T, Nagai Y, Takaishi K, Nagao Y, Oshima-Hasegawa N, Mitsukawa S, Mimura N, Takeuchi M, Ohwada C, Iseki T, Ota S, Nakaseko C, Sakaida E. [MALT lymphoma accompanied by elevated serum IgM levels mimicking Waldenström's macroglobulinemia]. Rinsho Ketsueki. 2018; 59(12):2600-2605. PMID: 30626796.
    Citations:    Fields:    
  44. Pak K, Uno H, Kim DH, Tian L, Kane RC, Takeuchi M, Fu H, Claggett B, Wei LJ. Interpretability of Cancer Clinical Trial Results Using Restricted Mean Survival Time as an Alternative to the Hazard Ratio. JAMA Oncol. 2017 12 01; 3(12):1692-1696. PMID: 28975263.
    Citations: 3     Fields:    
  45. Sunakawa Y, Tsuji A, Denda T, Segawa Y, Negoro Y, Shimada K, Kochi M, Nakamura M, Kotaka M, Tanioka H, Takagane A, Tani S, Yamaguchi T, Watanabe T, Takeuchi M, Fujii M, Ichikawa W. CEA Response and Depth of Response (DpR) to Predict Clinical Outcomes of First-Line Cetuximab Treatment for Metastatic Colorectal Cancer. Target Oncol. 2017 12; 12(6):787-794. PMID: 29064002.
    Citations:    Fields:    Translation:Humans
  46. Maehara Y, Shirabe K, Kohnoe S, Emi Y, Oki E, Kakeji Y, Baba H, Ikeda M, Kobayashi M, Takayama T, Natsugoe S, Haraguchi M, Yoshida K, Terashima M, Sasako M, Yamaue H, Kokudo N, Uesaka K, Uemoto S, Kosuge T, Sawa Y, Shimada M, Doki Y, Yamamoto M, Taketomi A, Takeuchi M, Akazawa K, Yamanaka T, Shimokawa M. Erratum to: Impact of intra-abdominal absorbable sutures on surgical site infection in gastrointestinal and hepato-biliary-pancreatic surgery: results of a multicenter, randomized, prospective, phase II clinical trial. Surg Today. 2017 12; 47(12):1539-1540. PMID: 28956067.
    Citations:    Fields:    
  47. Sunakawa Y, Satake H, Miyamoto Y, Nakamura M, Nakayama H, Higuchi A, Takeuchi M, Fujii M, Sekikawa T, Ichikawa W. Interim safety analysis of a phase II trial of modified-FOXFOXIRI plus bevacizumab for RAS mutant mCRC (JACCRO CC-11). Ann Oncol. 2017 Oct; 28 Suppl 9:ix91. PMID: 32120734.
    Citations:    
  48. Kirito K, Suzuki K, Miyamura K, Takeuchi M, Handa H, Okamoto S, Gadbaw B, Yamauchi K, Amagasaki T, Ito K, Hino M. Ruxolitinib is effective and safe in Japanese patients with hydroxyurea-resistant or hydroxyurea-intolerant polycythemia vera with splenomegaly. Int J Hematol. 2018 Feb; 107(2):173-184. PMID: 28956263.
    Citations:    Fields:    Translation:Humans
  49. Kimura Y, Fujii M, Masuishi T, Nishikawa K, Kunisaki C, Matsusaka S, Segawa Y, Nakamura M, Sasaki K, Nagao N, Hatachi Y, Yuasa Y, Asami S, Takeuchi M, Furukawa H, Nakajima T. Multicenter phase II study of trastuzumab plus S-1 alone in elderly patients with HER2-positive advanced gastric cancer (JACCRO GC-06). Gastric Cancer. 2018 May; 21(3):421-427. PMID: 28936560.
    Citations:    Fields:    Translation:HumansCTClinical Trials
  50. Kudo M, Moriguchi M, Numata K, Hidaka H, Tanaka H, Ikeda M, Kawazoe S, Ohkawa S, Sato Y, Kaneko S, Furuse J, Takeuchi M, Fang X, Date Y, Takeuchi M, Okusaka T. S-1 versus placebo in patients with sorafenib-refractory advanced hepatocellular carcinoma (S-CUBE): a randomised, double-blind, multicentre, phase 3 trial. Lancet Gastroenterol Hepatol. 2017 06; 2(6):407-417. PMID: 28497756.
    Citations: 4     Fields:    Translation:HumansCTClinical Trials
  51. Miyagawa S, Domae K, Yoshikawa Y, Fukushima S, Nakamura T, Saito A, Sakata Y, Hamada S, Toda K, Pak K, Takeuchi M, Sawa Y. Phase I Clinical Trial of Autologous Stem Cell-Sheet Transplantation Therapy for Treating Cardiomyopathy. J Am Heart Assoc. 2017 Apr 05; 6(4). PMID: 28381469.
    Citations: 12     Fields:    Translation:HumansCTClinical Trials
  52. Maehara Y, Shirabe K, Kohnoe S, Emi Y, Oki E, Kakeji Y, Baba H, Ikeda M, Kobayashi M, Takayama T, Natsugoe S, Haraguchi M, Yoshida K, Terashima M, Sasako M, Yamaue H, Kokudo N, Uesaka K, Uemoto S, Kosuge T, Sawa Y, Shimada M, Doki Y, Yamamoto M, Taketomi A, Takeuchi M, Akazawa K, Yamanaka T, Shimokawa M. Impact of intra-abdominal absorbable sutures on surgical site infection in gastrointestinal and hepato-biliary-pancreatic surgery: results of a multicenter, randomized, prospective, phase II clinical trial. Surg Today. 2017 Sep; 47(9):1060-1071. PMID: 28233105.
    Citations:    Fields:    Translation:Humans
  53. Shimizu R, Ohwada C, Nagao Y, Togasaki E, Kawajiri C, Muto T, Tsukamoto S, Sakai S, Takeda Y, Mimura N, Takeuchi M, Sakaida E, Iseki T, Nakaseko C. The Successful Treatment of a Cord Blood Transplant Recipient with Varicella Zoster Virus Meningitis, Radiculitis and Myelitis with Foscarnet. Intern Med. 2017; 56(3):353-356. PMID: 28154282.
    Citations:    Fields:    Translation:HumansCells
  54. Tsuji A, Sunakawa Y, Ichikawa W, Nakamura M, Kochi M, Denda T, Yamaguchi T, Shimada K, Takagane A, Tani S, Kotaka M, Kuramochi H, Furushima K, Koike J, Yonemura Y, Takeuchi M, Fujii M, Nakajima T. Early Tumor Shrinkage and Depth of Response as Predictors of Favorable Treatment Outcomes in Patients with Metastatic Colorectal Cancer Treated with FOLFOX Plus Cetuximab (JACCRO CC-05). Target Oncol. 2016 12; 11(6):799-806. PMID: 27306648.
    Citations: 2     Fields:    Translation:Humans
  55. Muto T, Ohwada C, Takaishi K, Isshiki Y, Nagao Y, Hasegawa N, Kawajiri-Manako C, Togasaki E, Shimizu R, Tsukamoto S, Sakai S, Takeda Y, Mimura N, Takeuchi M, Sakaida E, Misawa S, Shimizu N, Iseki T, Kuwabara S, Nakaseko C. Safety and Efficacy of Granulocyte Colony-Stimulating Factor Monotherapy for Peripheral Blood Stem Cell Collection in POEMS Syndrome. Biol Blood Marrow Transplant. 2017 Feb; 23(2):361-363. PMID: 27840209.
    Citations: 1     Fields:    Translation:Humans
  56. Sugita Y, Ohwada C, Kawaguchi T, Muto T, Tsukamoto S, Takeda Y, Mimura N, Takeuchi M, Sakaida E, Shimizu N, Tanaka H, Abe D, Fukazawa M, Sugawara T, Aotsuka N, Nishiwaki K, Shono K, Ebinuma H, Fujimura K, Bujo H, Yokote K, Nakaseko C. Prognostic impact of serum soluble LR11 in newly diagnosed diffuse large B-cell lymphoma: A multicenter prospective analysis. Clin Chim Acta. 2016 Dec 01; 463:47-52. PMID: 27725222.
    Citations: 1     Fields:    Translation:Humans
  57. Sunakawa Y, Ichikawa W, Tsuji A, Denda T, Segawa Y, Negoro Y, Shimada K, Kochi M, Nakamura M, Kotaka M, Tanioka H, Takagane A, Tani S, Yamaguchi T, Watanabe T, Takeuchi M, Fujii M, Nakajima T. Prognostic Impact of Primary Tumor Location on Clinical Outcomes of Metastatic Colorectal Cancer Treated With Cetuximab Plus Oxaliplatin-Based Chemotherapy: A Subgroup Analysis of the JACCRO CC-05/06 Trials. Clin Colorectal Cancer. 2017 09; 16(3):e171-e180. PMID: 27856123.
    Citations: 12     Fields:    Translation:HumansCTClinical Trials
  58. Shimizu R, Muto T, Aoyama K, Choi K, Takeuchi M, Koide S, Hasegawa N, Isshiki Y, Togasaki E, Kawajiri-Manako C, Nagao Y, Tsukamoto S, Sakai S, Takeda Y, Mimura N, Ohwada C, Sakaida E, Iseki T, Starczynowski DT, Iwama A, Yokote K, Nakaseko C. Possible role of intragenic DNA hypermethylation in gene silencing of the tumor suppressor gene NR4A3 in acute myeloid leukemia. Leuk Res. 2016 11; 50:85-94. PMID: 27697661.
    Citations: 1     Fields:    Translation:HumansCells
  59. Sato T, Hayakawa K, Tomita N, Noda M, Kamikonya N, Watanabe T, Kato D, Sakai Y, Hiraoka M, Shimada M, Ikushima H, Baba H, Oya N, Oya M, Nemoto-Murofushi K, Takeuchi M, Watanabe M. A multicenter phase I study of preoperative chemoradiotherapy with S-1 and irinotecan for locally advanced lower rectal cancer (SAMRAI-1). Radiother Oncol. 2016 08; 120(2):222-7. PMID: 27317556.
    Citations:    Fields:    Translation:HumansCTClinical Trials
  60. Kimura K, Takeuchi M, Hasegawa N, Togasaki E, Shimizu R, Kawajiri C, Muto T, Tsukamoto S, Takeda Y, Ohwada C, Sakaida E, Sakai S, Mimura N, Ota S, Iseki T, Nakaseko C. Severe stomatitis and ileocecal perforation developed after all-trans retinoic acid monotherapy in an HLA-B51-positive patient with acute promyelocytic leukemia. Rinsho Ketsueki. 2016 06; 57(6):765-70. PMID: 27384858.
    Citations:    Fields:    Translation:Humans
  61. Matsui S, Takeda Y, Isshiki Y, Yamazaki A, Nakao S, Takaishi K, Nagao Y, Hasegawa N, Togasaki E, Shimizu R, Kawajiri C, Sakai S, Mimura N, Takeuchi M, Ohwada C, Sakaida E, Iseki T, Imadome K, Nakaseko C. Chronic active Epstein-Barr virus infection with marked pericardial effusion successfully treated with allogeneic peripheral blood stem cell transplantation. Rinsho Ketsueki. 2016 05; 57(5):624-9. PMID: 27263789.
    Citations:    Fields:    Translation:HumansCells
  62. Sunakawa Y, Yang D, Moran M, Astrow SH, Tsuji A, Stephens C, Zhang W, Cao S, Takahashi T, Denda T, Shimada K, Kochi M, Nakamura M, Kotaka M, Segawa Y, Masuishi T, Takeuchi M, Fujii M, Nakajima T, Ichikawa W, Lenz HJ. Combined assessment of EGFR-related molecules to predict outcome of 1st-line cetuximab-containing chemotherapy for metastatic colorectal cancer. Cancer Biol Ther. 2016 07 02; 17(7):751-9. PMID: 27104867.
    Citations: 3     Fields:    Translation:Humans
  63. Hasunuma T, Tohkin M, Kaniwa N, Jang IJ, Yimin C, Kaneko M, Saito Y, Takeuchi M, Watanabe H, Yamazoe Y, Uyama Y, Kawai S. Absence of ethnic differences in the pharmacokinetics of moxifloxacin, simvastatin, and meloxicam among three East Asian populations and Caucasians. Br J Clin Pharmacol. 2016 06; 81(6):1078-90. PMID: 26774055.
    Citations: 7     Fields:    Translation:HumansCTClinical Trials
  64. Ueshima K, Itoh H, Kanazawa N, Komuro I, Nagai R, Takeuchi M, Yamazaki T. Rationale and Design of the Standard Versus Intensive Statin Therapy for Hypercholesterolemic Patients with Diabetic Retinopathy (EMPATHY) Study: a Randomized Controlled Trial. J Atheroscler Thromb. 2016 Aug 01; 23(8):976-90. PMID: 26961114.
    Citations: 2     Fields:    Translation:Humans
  65. Aotani E, Hamano T, Gemma A, Takeuchi M, Takebayashi T, Kobayashi K. Identification of adverse events that have a negative impact on quality of life in a clinical trial comparing docetaxel versus S-1 with cisplatin in lung cancer. Int J Clin Oncol. 2016 Oct; 21(5):836-842. PMID: 26879651.
    Citations:    Fields:    Translation:HumansCTClinical Trials
  66. Tsukamoto S, Nagao Y, Yamazaki A, Sugita Y, Muto T, Sakai S, Takeda Y, Mimura N, Takeuchi M, Ohwada C, Sakaida E, Yokote K, Iseki T, Nakaseko C. Successful Allogeneic Stem Cell Transplantation for Severe Aplastic Anemia after Treatment of Lymphoproliferative Disorder Caused by Rabbit Antithymocyte Globulin. Intern Med. 2015; 54(24):3197-200. PMID: 26666612.
    Citations: 1     Fields:    Translation:HumansAnimals
  67. Umayahara K, Takekuma M, Hirashima Y, Noda SE, Ohno T, Miyagi E, Hirahara F, Hirata E, Kondo E, Tabata T, Nagai Y, Aoki Y, Wakatsuki M, Takeuchi M, Toita T, Takeshima N, Takizawa K. Phase II study of concurrent chemoradiotherapy with weekly cisplatin and paclitaxel in patients with locally advanced uterine cervical cancer: The JACCRO GY-01 trial. Gynecol Oncol. 2016 Feb; 140(2):253-8. PMID: 26701414.
    Citations: 3     Fields:    Translation:HumansCTClinical Trials
  68. Hironaka S, Sugimoto N, Yamaguchi K, Moriwaki T, Komatsu Y, Nishina T, Tsuji A, Nakajima TE, Gotoh M, Machida N, Bando H, Esaki T, Emi Y, Sekikawa T, Matsumoto S, Takeuchi M, Boku N, Baba H, Hyodo I. S-1 plus leucovorin versus S-1 plus leucovorin and oxaliplatin versus S-1 plus cisplatin in patients with advanced gastric cancer: a randomised, multicentre, open-label, phase 2 trial. Lancet Oncol. 2016 Jan; 17(1):99-108. PMID: 26640036.
    Citations: 8     Fields:    Translation:HumansCTClinical Trials
  69. Whittle AJ, Jiang M, Peirce V, Relat J, Virtue S, Ebinuma H, Fukamachi I, Yamaguchi T, Takahashi M, Murano T, Tatsuno I, Takeuchi M, Nakaseko C, Jin W, Jin Z, Campbell M, Schneider WJ, Vidal-Puig A, Bujo H. Soluble LR11/SorLA represses thermogenesis in adipose tissue and correlates with BMI in humans. Nat Commun. 2015 Nov 20; 6:8951. PMID: 26584636.
    Citations: 10     Fields:    Translation:HumansAnimalsCells
  70. Muto T, Ohwada C, Sawai S, Beppu M, Tsukamoto S, Takeda Y, Mimura N, Takeuchi M, Sakaida E, Sogawa K, Misawa S, Shimizu N, Iseki T, Nomura F, Kuwabara S, Nakaseko C. Acutely deteriorated extravascular volume overload during peripheral blood stem cell mobilization in POEMS syndrome: A case series with cytokine analysis. Transfus Apher Sci. 2016 Apr; 54(2):276-81. PMID: 26586169.
    Citations:    Fields:    Translation:HumansCells
  71. Tanigawa N, Yamaue H, Ohyama S, Sakuramoto S, Inada T, Kodera Y, Kitagawa Y, Omura K, Terashima M, Sakata Y, Nashimoto A, Yamaguchi T, Chin K, Nomura E, Lee SW, Takeuchi M, Fujii M, Nakajima T. Exploratory phase II trial in a multicenter setting to evaluate the clinical value of a chemosensitivity test in patients with gastric cancer (JACCRO-GC 04, Kubota memorial trial). Gastric Cancer. 2016 Apr; 19(2):350-360. PMID: 26385385.
    Citations: 2     Fields:    Translation:HumansCTClinical Trials
  72. Sugiyama A, Ito S, Sugita Y, Shimada J, Takeuchi M, Hirano S, Kuwabara S. Brachial Plexus Involvement of Myeloid Sarcoma Detected by Reconstruction Magnetic Resonance Neurography. Intern Med. 2015; 54(17):2251-3. PMID: 26328656.
    Citations:    Fields:    Translation:Humans
  73. Ri M, Miyata H, Aikou S, Seto Y, Akazawa K, Takeuchi M, Matsui Y, Konno H, Gotoh M, Mori M, Motomura N, Takamoto S, Sawa Y, Kuwano H, Kokudo N. Effects of body mass index (BMI) on surgical outcomes: a nationwide survey using a Japanese web-based database. Surg Today. 2015 Oct; 45(10):1271-9. PMID: 26263911.
    Citations: 8     Fields:    Translation:Humans
  74. Miyazaki Y, Azuma A, Inase N, Taniguchi H, Ogura T, Inoue E, Takeuchi M, Yoshizawa Y, Sugiyama Y, Kudoh S. Cyclosporine A combined with low-dose corticosteroid treatment in patients with idiopathic pulmonary fibrosis. Respir Investig. 2015 Nov; 53(6):288-95. PMID: 26521106.
    Citations: 2     Fields:    Translation:Humans
  75. Muto T, Ohwada C, Yamazaki A, Sugita Y, Tsukamoto S, Sakai S, Takeda Y, Mimura N, Takeuchi M, Sakaida E, Iseki T, Shimizu N, Morio T, Nakaseko C. Long-term complete remission by infusion of ex vivo-expanded donor-derived CD4(+) lymphocytes for treating an early relapse of Hodgkin lymphoma after cord blood transplantation. Leuk Lymphoma. 2016; 57(1):230-2. PMID: 25962436.
    Citations:    Fields:    Translation:HumansCells
  76. Ohwada C, Yamazaki A, Kawaguchi T, Sugita Y, Takeuchi M, Shimizu N, Sakaida E, Takeda Y, Tsukamoto S, Muto T, Jiang M, Higashi M, Yokote K, Tamaru J, Bujo H, Nakaseko C. Serum soluble LR11, a novel tumor derived biomarker associated with the outcome of patients with diffuse large B-cell lymphoma. Leuk Lymphoma. 2015; 56(10):2982-5. PMID: 25676033.
    Citations:    Fields:    Translation:Humans
  77. Muto T, Takeuchi M, Yamazaki A, Sugita Y, Tsukamoto S, Sakai S, Takeda Y, Mimura N, Ohwada C, Sakaida E, Aotsuka N, Iseki T, Nakaseko C. Efficacy of myeloablative allogeneic hematopoietic stem cell transplantation in adult patients with MLL-ELL-positive acute myeloid leukemia. Int J Hematol. 2015 Jul; 102(1):86-92. PMID: 25758097.
    Citations: 1     Fields:    Translation:Humans
  78. Watanabe Y, Shiraishi K, Takahashi F, Yoshida A, Suzuki K, Asamura H, Takeuchi M, Furuta K, Tsuta K. Biomarker expression and druggable gene alterations for development of an appropriate therapeutic protocol for pulmonary adenosquamous carcinoma. Histopathology. 2015 Jun; 66(7):939-48. PMID: 25257380.
    Citations:    Fields:    Translation:Humans
  79. Yamazaki K, Kuwano H, Ojima H, Otsuji T, Kato T, Shimada K, Hyodo I, Nishina T, Shirao K, Esaki T, Ohishi T, Denda T, Takeuchi M, Boku N. A randomized phase II study of combination therapy with S-1, oral leucovorin, and oxaliplatin (SOL) and mFOLFOX6 in patients with previously untreated metastatic colorectal cancer. Cancer Chemother Pharmacol. 2015 Mar; 75(3):569-77. PMID: 25575764.
    Citations: 2     Fields:    Translation:HumansCTClinical Trials
  80. Sugita Y, Ohwada C, Nagao Y, Kawajiri C, Shimizu R, Togasaki E, Yamazaki A, Muto T, Sakai S, Takeda Y, Mimura N, Takeuchi M, Sakaida E, Iseki T, Yokote K, Nakaseko C. Early-Onset Severe Diffuse Alveolar Hemorrhage after Bortezomib Administration Suggestive of Pulmonary Involvement of Myeloma Cells. J Clin Exp Hematop. 2015; 55(3):163-8. PMID: 26763365.
    Citations:    Fields:    Translation:Humans
  81. Tanaka H, Kawajiri C, Sakai S, Takeda Y, Kawaguchi T, Mimura N, Sakaida E, Ohwada C, Takeuchi M, Hashimoto S, Takagi T, Nakaseko C. Gradually-Deteriorating Liver Function due to Iron Overload Over Four Years after Allogeneic Stem Cell Transplantation. J Clin Exp Hematop. 2015; 55(2):109-12. PMID: 26490524.
    Citations:    Fields:    Translation:Humans
  82. Nakamoto S, Kanda T, Nakaseko C, Sakaida E, Ohwada C, Takeuchi M, Takeda Y, Mimura N, Iseki T, Wu S, Arai M, Imazeki F, Saito K, Shirasawa H, Yokosuka O. Reactivation of hepatitis B virus in hematopoietic stem cell transplant recipients in Japan: efficacy of nucleos(t)ide analogues for prevention and treatment. Int J Mol Sci. 2014 Nov 21; 15(11):21455-67. PMID: 25421241.
    Citations: 7     Fields:    Translation:HumansCells
  83. Mizuno Y, Nomoto M, Hasegawa K, Hattori N, Kondo T, Murata M, Takeuchi M, Takahashi M, Tomida T. Rotigotine vs ropinirole in advanced stage Parkinson's disease: a double-blind study. Parkinsonism Relat Disord. 2014 Dec; 20(12):1388-93. PMID: 25455692.
    Citations: 4     Fields:    Translation:Humans
  84. Nomoto M, Mizuno Y, Kondo T, Hasegawa K, Murata M, Takeuchi M, Ikeda J, Tomida T, Hattori N. Transdermal rotigotine in advanced Parkinson's disease: a randomized, double-blind, placebo-controlled trial. J Neurol. 2014 Oct; 261(10):1887-93. PMID: 25022939.
    Citations: 5     Fields:    Translation:Humans
  85. Uno H, Claggett B, Tian L, Inoue E, Gallo P, Miyata T, Schrag D, Takeuchi M, Uyama Y, Zhao L, Skali H, Solomon S, Jacobus S, Hughes M, Packer M, Wei LJ. Moving beyond the hazard ratio in quantifying the between-group difference in survival analysis. J Clin Oncol. 2014 Aug 01; 32(22):2380-5. PMID: 24982461.
    Citations: 36     Fields:    Translation:Humans
  86. Isshiki Y, Ohwada C, Togasaki E, Shimizu R, Hasegawa N, Yamazaki A, Sugita Y, Kawaguchi T, Tsukamoto S, Sakai S, Takeda Y, Takeuchi M, Sakaida E, Shimizu N, Ota S, Yokote K, Iseki T, Nakaseko C. Acute myeloid leukemia concurrent with spinal epidural extramedullary myeloid sarcoma accompanied by a high CD25 expression and the FLT3-ITD mutation. Intern Med. 2014; 53(11):1159-64. PMID: 24881741.
    Citations: 1     Fields:    Translation:Humans
  87. Akamatsu N, Sugawara Y, Kokudo N, Eguchi S, Fujiwara T, Ohdan H, Nagano H, Taketomi A, Kitagawa Y, Shimada M, Ku Y, Yanaga K, Shirabe K, Ikegami T, Mizokami M, Takeuchi M, Maehara Y. Outcomes of living donor liver transplantation for hepatitis C virus-positive recipients in Japan: results of a nationwide survey. Transpl Int. 2014 Aug; 27(8):767-74. PMID: 24684710.
    Citations: 6     Fields:    Translation:Humans
  88. Tsukamoto S, Takeuchi M, Kawaguchi T, Togasaki E, Yamazaki A, Sugita Y, Muto T, Sakai S, Takeda Y, Ohwada C, Sakaida E, Shimizu N, Nishii K, Jiang M, Yokote K, Bujo H, Nakaseko C. Tetraspanin CD9 modulates ADAM17-mediated shedding of LR11 in leukocytes. Exp Mol Med. 2014 Apr 04; 46:e89. PMID: 24699135.
    Citations: 6     Fields:    Translation:HumansCells
  89. Miyata T, Ando T, Hiragi H, Watanabe K, Yamamoto F, Vaughan DE, Kurokawa T, Oshima Y, van Ypersele de Strihou C, Takeuchi M. Drug discovery in renal disease--towards a more efficient framework. Nat Rev Nephrol. 2014 May; 10(5):290-6. PMID: 24642801.
    Citations:    Fields:    Translation:Humans
  90. Kawaguchi T, Ohwada C, Takeuchi M, Shimizu N, Sakaida E, Takeda Y, Sakai S, Tsukamoto S, Yamazaki A, Sugita Y, Higashi M, Fujikawa K, Matsue K, Yokote K, Tamaru J, Bujo H, Nakaseko C. Potential utility of serum soluble LR11 as a diagnostic biomarker for intravascular large B-cell lymphoma. Leuk Lymphoma. 2014 Oct; 55(10):2391-4. PMID: 24401112.
    Citations: 1     Fields:    Translation:Humans
  91. Higuchi K, Tanabe S, Shimada K, Hosaka H, Sasaki E, Nakayama N, Takeda Y, Moriwaki T, Amagai K, Sekikawa T, Sakuyama T, Kanda T, Sasaki T, Azuma M, Takahashi F, Takeuchi M, Koizumi W. Biweekly irinotecan plus cisplatin versus irinotecan alone as second-line treatment for advanced gastric cancer: a randomised phase III trial (TCOG GI-0801/BIRIP trial). Eur J Cancer. 2014 May; 50(8):1437-45. PMID: 24560487.
    Citations: 21     Fields:    Translation:HumansCTClinical Trials
  92. Kawajiri C, Tanaka H, Hashimoto S, Takeda Y, Sakai S, Takagi T, Takeuchi M, Ohwada C, Sakaida E, Shimizu N, Nakaseko C. Successful treatment of Philadelphia chromosome-positive mixed phenotype acute leukemia by appropriate alternation of second-generation tyrosine kinase inhibitors according to BCR-ABL1 mutation status. Int J Hematol. 2014 Apr; 99(4):513-8. PMID: 24532437.
    Citations: 3     Fields:    Translation:Humans
  93. Fujimura K, Ebinuma H, Fukamachi I, Ohwada C, Kawaguchi T, Shimizu N, Takeuchi M, Sakaida E, Jiang M, Nakaseko C, Bujo H. Circulating LR11 is a novel soluble-receptor marker for early-stage clinical conditions in patients with non-Hodgkin's lymphoma. Clin Chim Acta. 2014 Mar 20; 430:48-54. PMID: 24394293.
    Citations: 2     Fields:    Translation:Humans
  94. Koizumi W, Kim YH, Fujii M, Kim HK, Imamura H, Lee KH, Hara T, Chung HC, Satoh T, Cho JY, Hosaka H, Tsuji A, Takagane A, Inokuchi M, Tanabe K, Okuno T, Ogura M, Yoshida K, Takeuchi M, Nakajima T. Addition of docetaxel to S-1 without platinum prolongs survival of patients with advanced gastric cancer: a randomized study (START). J Cancer Res Clin Oncol. 2014 Feb; 140(2):319-28. PMID: 24366758.
    Citations: 33     Fields:    Translation:HumansCTClinical Trials
  95. Sasamura H, Nakaya H, Julius S, Tomotsugu N, Sato Y, Takahashi F, Takeuchi M, Murakami M, Ryuzaki M, Itoh H. Feasibility of regression of hypertension using contemporary antihypertensive agents. Am J Hypertens. 2013 Dec; 26(12):1381-8. PMID: 24190927.
    Citations: 4     Fields:    Translation:Humans
  96. Kochi M, Akiyama Y, Aoki T, Hagiwara K, Takahashi T, Hironaka K, Teranishi F, Osuka F, Takeuchi M, Fujii M, Nakajima T. FOLFIRI plus bevacizumab as a first-line treatment for Japanese patients with metastatic colorectal cancer: a JACCRO CC-03 multicenter phase II study. Cancer Chemother Pharmacol. 2013 Nov; 72(5):1097-102. PMID: 24057041.
    Citations: 1     Fields:    Translation:HumansCTClinical Trials
  97. Tsukamoto S, Ota S, Ohwada C, Takeda Y, Takeuchi M, Sakaida E, Shimizu N, Yokote K, Iseki T, Nakaseko C. Extramedullary blast crisis of chronic myelogenous leukemia as an initial presentation. Leuk Res Rep. 2013; 2(2):67-9. PMID: 24371785.
    Citations: 6     
  98. Tsuta K, Kawago M, Inoue E, Yoshida A, Takahashi F, Sakurai H, Watanabe SI, Takeuchi M, Furuta K, Asamura H, Tsuda H. The utility of the proposed IASLC/ATS/ERS lung adenocarcinoma subtypes for disease prognosis and correlation of driver gene alterations. Lung Cancer. 2013 Sep; 81(3):371-376. PMID: 23891509.
    Citations: 50     Fields:    Translation:Humans
  99. Tsukamoto S, Nakaseko C, Takeuchi M, Kumagai K, Komatsu T, Tanaka H, Hara S, Koizumi M, Imai H, Yokota A, Takeuchi M, Inokuchi K, Matsuura Y, Aotsuka N, Wakita H. Safety and efficacy of romiplostim in patients with eltrombopag-resistant or -intolerant immune thrombocytopenia. Br J Haematol. 2013 Oct; 163(2):286-9. PMID: 23862773.
    Citations: 4     Fields:    Translation:Humans
  100. Kawaguchi T, Ohwada C, Takeuchi M, Shimizu N, Sakaida E, Takeda Y, Sakai S, Tsukamoto S, Yamazaki A, Sugita Y, Jiang M, Higashi M, Yokote K, Tamaru J, Bujo H, Nakaseko C. LR11: a novel biomarker identified in follicular lymphoma. Br J Haematol. 2013 Oct; 163(2):277-80. PMID: 23848957.
    Citations: 2     Fields:    Translation:Humans
  101. Mizuno Y, Nomoto M, Kondo T, Hasegawa K, Murata M, Takeuchi M, Ikeda J, Tomida T, Hattori N. Transdermal rotigotine in early stage Parkinson's disease: a randomized, double-blind, placebo-controlled trial. Mov Disord. 2013 Sep; 28(10):1447-50. PMID: 23801585.
    Citations: 4     Fields:    Translation:Humans
  102. Nagatsuma AK, Shimizu C, Takahashi F, Tsuda H, Saji S, Hojo T, Sugano K, Takeuchi M, Fujii H, Fujiwara Y. Impact of recent parity on histopathological tumor features and breast cancer outcome in premenopausal Japanese women. Breast Cancer Res Treat. 2013 Apr; 138(3):941-50. PMID: 23553566.
    Citations: 6     Fields:    Translation:Humans
  103. Tanaka H, Shimizu N, Tougasaki E, Kawajiri C, Hashimoto S, Takeda Y, Sakai S, Takeuchi M, Ohwada C, Sakaida E, Takagi T, Nakaseko C. Successful treatment by azacitidine therapy of intestinal Behçet's disease associated with myelodysplastic syndrome. Int J Hematol. 2013 Apr; 97(4):520-4. PMID: 23519573.
    Citations: 5     Fields:    Translation:Humans
  104. Nishii K, Nakaseko C, Jiang M, Shimizu N, Takeuchi M, Schneider WJ, Bujo H. The soluble form of LR11 protein is a regulator of hypoxia-induced, urokinase-type plasminogen activator receptor (uPAR)-mediated adhesion of immature hematological cells. J Biol Chem. 2013 Apr 26; 288(17):11877-86. PMID: 23486467.
    Citations: 3     Fields:    Translation:HumansAnimalsCells
  105. Kako S, Kanamori H, Kobayashi N, Shigematsu A, Nannya Y, Nakamae M, Shigeno K, Suzukawa K, Takeuchi M, Tsuzuki M, Usuki K, Hatanaka K, Ogawa K, Mitani K, Nawa Y, Hatta Y, Mizuno I, Kanda Y. Outcome after first relapse in adult patients with Philadelphia chromosome-negative acute lymphoblastic leukaemia. Br J Haematol. 2013 Apr; 161(1):95-103. PMID: 23368421.
    Citations: 5     Fields:    Translation:Humans
  106. Inoue Y, Hirata K, Uchimura N, Kuroda K, Hattori N, Takeuchi M. Gabapentin enacarbil in Japanese patients with restless legs syndrome: a 12-week, randomized, double-blind, placebo-controlled, parallel-group study. Curr Med Res Opin. 2013 Jan; 29(1):13-21. PMID: 23121149.
    Citations: 10     Fields:    Translation:Humans
  107. Fuji T, Nakamura M, Takeuchi M. Darexaban for the prevention of venous thromboembolism in Asian patients undergoing orthopedic surgery: results from 2 randomized, placebo-controlled, double-blind studies. Clin Appl Thromb Hemost. 2014 Mar; 20(2):199-211. PMID: 22952213.
    Citations: 3     Fields:    Translation:HumansCTClinical Trials
  108. Yoshida T, Akahoshi F, Sakashita H, Kitajima H, Nakamura M, Sonda S, Takeuchi M, Tanaka Y, Ueda N, Sekiguchi S, Ishige T, Shima K, Nabeno M, Abe Y, Anabuki J, Soejima A, Yoshida K, Takashina Y, Ishii S, Kiuchi S, Fukuda S, Tsutsumiuchi R, Kosaka K, Murozono T, Nakamaru Y, Utsumi H, Masutomi N, Kishida H, Miyaguchi I, Hayashi Y. Discovery and preclinical profile of teneligliptin (3-[(2S,4S)-4-[4-(3-methyl-1-phenyl-1H-pyrazol-5-yl)piperazin-1-yl]pyrrolidin-2-ylcarbonyl]thiazolidine): a highly potent, selective, long-lasting and orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes. Bioorg Med Chem. 2012 Oct 01; 20(19):5705-19. PMID: 22959556.
    Citations: 18     Fields:    Translation:HumansAnimals
  109. Yamauchi T, Nakamura N, Hiramoto M, Yuri M, Yokota H, Naitou M, Takeuchi M, Yamanaka K, Kita A, Nakahara T, Kinoyama I, Matsuhisa A, Kaneko N, Koutoku H, Sasamata M, Kobori M, Katou M, Tawara S, Kawabata S, Furuichi K. Sepantronium bromide (YM155) induces disruption of the ILF3/p54(nrb) complex, which is required for survivin expression. Biochem Biophys Res Commun. 2012 Sep 07; 425(4):711-6. PMID: 22842455.
    Citations: 28     Fields:    Translation:HumansCells
  110. Yoshida T, Akahoshi F, Sakashita H, Sonda S, Takeuchi M, Tanaka Y, Nabeno M, Kishida H, Miyaguchi I, Hayashi Y. Fused bicyclic heteroarylpiperazine-substituted L-prolylthiazolidines as highly potent DPP-4 inhibitors lacking the electrophilic nitrile group. Bioorg Med Chem. 2012 Aug 15; 20(16):5033-41. PMID: 22824762.
    Citations: 1     Fields:    Translation:HumansAnimalsCells
  111. Sakai S, Nakaseko C, Takeuchi M, Ohwada C, Shimizu N, Tsukamoto S, Kawaguchi T, Jiang M, Sato Y, Ebinuma H, Yokote K, Iwama A, Fukamachi I, Schneider WJ, Saito Y, Bujo H. Circulating soluble LR11/SorLA levels are highly increased and ameliorated by chemotherapy in acute leukemias. Clin Chim Acta. 2012 Oct 09; 413(19-20):1542-8. PMID: 22750733.
    Citations: 4     Fields:    Translation:HumansCells
  112. Sagae S, Aoki D, Susumu N, Okamoto A, Aotani E, Takeuchi M, Mandai M. [Current movement in global clinical trials--discussion at Gynecologic Cancer Intergroup (GCIG)]. Nihon Rinsho. 2012 Jun; 70 Suppl 4:59-66. PMID: 23156218.
    Citations:    Fields:    Translation:Humans
  113. Cheng Q, Ling X, Haller A, Nakahara T, Yamanaka K, Kita A, Koutoku H, Takeuchi M, Brattain MG, Li F. Suppression of survivin promoter activity by YM155 involves disruption of Sp1-DNA interaction in the survivin core promoter. Int J Biochem Mol Biol. 2012; 3(2):179-97. PMID: 22773958.
    Citations: 35     
  114. Homma S, Azuma A, Taniguchi H, Ogura T, Mochiduki Y, Sugiyama Y, Nakata K, Yoshimura K, Takeuchi M, Kudoh S. Efficacy of inhaled N-acetylcysteine monotherapy in patients with early stage idiopathic pulmonary fibrosis. Respirology. 2012 Apr; 17(3):467-77. PMID: 22257422.
    Citations: 24     Fields:    Translation:Humans
  115. Nakamura N, Yamauchi T, Hiramoto M, Yuri M, Naito M, Takeuchi M, Yamanaka K, Kita A, Nakahara T, Kinoyama I, Matsuhisa A, Kaneko N, Koutoku H, Sasamata M, Yokota H, Kawabata S, Furuichi K. Interleukin enhancer-binding factor 3/NF110 is a target of YM155, a suppressant of survivin. Mol Cell Proteomics. 2012 Jul; 11(7):M111.013243. PMID: 22442257.
    Citations: 21     Fields:    Translation:HumansCells
  116. Inoue K, Narukawa M, Takeuchi M. Factors affecting efficacy and safety of add-on combination chemotherapy for non-small-cell lung cancer: a literature-based pooled analysis of randomized controlled trials. Lung. 2012 Aug; 190(4):355-64. PMID: 22350680.
    Citations: 1     Fields:    Translation:Humans
  117. Sato R, Watanabe H, Shirai K, Ohki S, Genma R, Morita H, Inoue E, Takeuchi M, Maekawa M, Nakamura H. A cross-sectional study of glucose regulation in young adults with very low birth weight: impact of male gender on hyperglycaemia. BMJ Open. 2012; 2(1):e000327. PMID: 22307095.
    Citations: 5     Fields:    
  118. Louisa M, Takeuchi M, Setiabudy R, Takeuchi M. Current status of phase I clinical trials in Asia: an academic perspectives. Acta Med Indones. 2012 Jan; 44(1):71-7. PMID: 22451190.
    Citations: 2     Fields:    Translation:Humans
  119. Tsukamoto S, Takeuchi M, Kawajiri C, Tanaka S, Nagao Y, Sugita Y, Yamazaki A, Kawaguchi T, Muto T, Sakai S, Takeda Y, Ohwada C, Sakaida E, Shimizu N, Yokote K, Iseki T, Nakaseko C. Posterior reversible encephalopathy syndrome in an adult patient with acute lymphoblastic leukemia after remission induction chemotherapy. Int J Hematol. 2012 Feb; 95(2):204-8. PMID: 22160836.
    Citations: 6     Fields:    Translation:Humans
  120. Ohwada C, Takeuchi M, Kawaguchi T, Tsukamoto S, Sakai S, Takeda Y, Abe D, Sakaida E, Shimizu N, Yokote K, Iseki T, Nakaseko C. Successful treatment with recombinant soluble thrombomodulin of two cases of sinusoidal obstructive syndrome/hepatic veno-occlusive disease after bone marrow transplantation. Am J Hematol. 2011 Oct; 86(10):886-8. PMID: 21818767.
    Citations: 5     Fields:    Translation:Humans
  121. Yamanaka K, Nakahara T, Yamauchi T, Kita A, Takeuchi M, Kiyonaga F, Kaneko N, Sasamata M. Antitumor activity of YM155, a selective small-molecule survivin suppressant, alone and in combination with docetaxel in human malignant melanoma models. Clin Cancer Res. 2011 Aug 15; 17(16):5423-31. PMID: 21737502.
    Citations: 35     Fields:    Translation:HumansAnimalsCells
  122. Nakahara T, Yamanaka K, Hatakeyama S, Kita A, Takeuchi M, Kinoyama I, Matsuhisa A, Nakano K, Shishido T, Koutoku H, Sasamata M. YM155, a novel survivin suppressant, enhances taxane-induced apoptosis and tumor regression in a human Calu 6 lung cancer xenograft model. Anticancer Drugs. 2011 Jun; 22(5):454-62. PMID: 21389848.
    Citations: 27     Fields:    Translation:HumansAnimalsCells
  123. Takeda Y, Nakaseko C, Tanaka H, Takeuchi M, Yui M, Saraya A, Miyagi S, Wang C, Tanaka S, Ohwada C, Sakaida E, Yamaguchi N, Yokote K, Hennighausen L, Iwama A. Direct activation of STAT5 by ETV6-LYN fusion protein promotes induction of myeloproliferative neoplasm with myelofibrosis. Br J Haematol. 2011 Jun; 153(5):589-98. PMID: 21492125.
    Citations: 5     Fields:    Translation:AnimalsCells
  124. Mimae T, Tsuta K, Takahashi F, Yoshida A, Kondo T, Murakami Y, Okada M, Takeuchi M, Asamura H, Tsuda H. Steroid receptor expression in thymomas and thymic carcinomas. Cancer. 2011 Oct 01; 117(19):4396-405. PMID: 21437890.
    Citations: 2     Fields:    Translation:Humans
  125. Kochi M, Ichikawa W, Meguro E, Shibata H, Fukui T, Nagase M, Hoshino Y, Takeuchi M, Fujii M, Nakajima T. Phase II study of FOLFOX4 with "wait and go" strategy as first-line treatment for metastatic colorectal cancer. Cancer Chemother Pharmacol. 2011 Nov; 68(5):1215-22. PMID: 21416138.
    Citations: 3     Fields:    Translation:HumansCTClinical Trials
  126. Nakahara T, Kita A, Yamanaka K, Mori M, Amino N, Takeuchi M, Tominaga F, Kinoyama I, Matsuhisa A, Kudou M, Sasamata M. Broad spectrum and potent antitumor activities of YM155, a novel small-molecule survivin suppressant, in a wide variety of human cancer cell lines and xenograft models. Cancer Sci. 2011 Mar; 102(3):614-21. PMID: 21205082.
    Citations: 53     Fields:    Translation:HumansAnimalsCells
  127. Louisa M, Takeuchi M, Takeuchi M, Setiabudy R. A meta-analysis on treatment effects of thiazolidinediones for type 2 diabetes mellitus in Asian populations. Acta Med Indones. 2011 Jan; 43(1):39-52. PMID: 21339545.
    Citations:    Fields:    Translation:Humans
  128. Sato R, Watanabe H, Genma R, Takeuchi M, Maekawa M, Nakamura H. ABCC8 polymorphism (Ser1369Ala): influence on severe hypoglycemia due to sulfonylureas. Pharmacogenomics. 2010 Dec; 11(12):1743-50. PMID: 21142918.
    Citations: 5     Fields:    Translation:HumansCells
  129. Fujiwara K, Aotani E, Hamano T, Nagao S, Yoshikawa H, Sugiyama T, Kigawa J, Aoki D, Katsumata N, Takeuchi M, Suzuki M. A randomized Phase II/III trial of 3 weekly intraperitoneal versus intravenous carboplatin in combination with intravenous weekly dose-dense paclitaxel for newly diagnosed ovarian, fallopian tube and primary peritoneal cancer. Jpn J Clin Oncol. 2011 Feb; 41(2):278-82. PMID: 20937602.
    Citations: 9     Fields:    Translation:Humans
  130. Kita A, Nakahara T, Takeuchi M, Kinoyama I, Yamanaka K, Minematsu T, Mitsuoka K, Fushiki H, Miyoshi S, Sasamata M, Miyata K. [Survivin supressant: a promising target for cancer therapy and pharmacological profiles of YM155]. Nihon Yakurigaku Zasshi. 2010 Oct; 136(4):198-203. PMID: 20948154.
    Citations: 3     Fields:    Translation:HumansAnimalsCells
  131. Nakashima K, Narukawa M, Kanazu Y, Takeuchi M. Differences between Japan and the United States in dosages of drugs recently approved in Japan. J Clin Pharmacol. 2011 Apr; 51(4):549-60. PMID: 20628171.
    Citations: 2     Fields:    Translation:Humans
  132. Hashimoto K, Fujimoto H, Kouno T, Koseki M, Yonemori K, Hirata T, Yunokawa M, Shimizu C, Katsumata N, Tamura K, Ando M, Takeuchi M, Nakanishi H, Komiyama M, Nakagawa T, Fujiwara Y. The incidence and management of metachronous testicular germ cell tumors in patients with extragonadal germ cell tumors. Urol Oncol. 2012 May-Jun; 30(3):319-24. PMID: 20471872.
    Citations:    Fields:    Translation:Humans
  133. Suzuki T, Takeuchi M, Saeki H, Yamazaki S, Koga H, Abe D, Nishimura M, Nakaseko C, Nakasa H, Nakamura H, Ariyoshi N, Kitada M. Super-acute onset of tumor lysis syndrome accompanied by hypercytokinemia during treatment of Hodgkin's lymphoma with ABVD chemotherapy. Clin Ther. 2010 Mar; 32(3):527-31. PMID: 20399989.
    Citations: 1     Fields:    Translation:Humans
  134. Horie Y, Hayashi N, Dugi K, Takeuchi M. Design, statistical analysis and sample size calculation of a phase IIb/III study of linagliptin versus voglibose and placebo. Trials. 2009 Sep 05; 10:82. PMID: 19732457.
    Citations: 1     Fields:    Translation:HumansCTClinical Trials
  135. Maruyama N, Takahashi F, Takeuchi M. Prediction of an outcome using trajectories estimated from a linear mixed model. J Biopharm Stat. 2009 Sep; 19(5):779-90. PMID: 20183443.
    Citations:    Fields:    Translation:Humans
  136. Hashimoto K, Yonemori K, Katsumata N, Hotchi M, Kouno T, Shimizu C, Tamura K, Ando M, Takeuchi M, Fujiwara Y. Factors that affect the duration of the interval between the completion of palliative chemotherapy and death. Oncologist. 2009 Jul; 14(7):752-9. PMID: 19596665.
    Citations: 12     Fields:    Translation:Humans
  137. Saijo N, Takeuchi M, Kunitoh H. Reasons for response differences seen in the V15-32, INTEREST and IPASS trials. Nat Rev Clin Oncol. 2009 May; 6(5):287-94. PMID: 19390555.
    Citations: 6     Fields:    Translation:Humans
  138. Yonemura M, Katsumata N, Hashimoto H, Satake S, Kaneko M, Kobayashi Y, Takashima A, Kato Y, Takeuchi M, Fujiwara Y, Yamamoto H, Hojo T. Randomized controlled study comparing two doses of intravenous granisetron (1 and 3 mg) for acute chemotherapy-induced nausea and vomiting in cancer patients: a non-inferiority trial. Jpn J Clin Oncol. 2009 Jul; 39(7):443-8. PMID: 19395466.
    Citations: 3     Fields:    Translation:HumansCTClinical Trials
  139. Funatogawa T, Funatogawa I, Takeuchi M. An autoregressive linear mixed effects model for the analysis of longitudinal data which include dropouts and show profiles approaching asymptotes. Stat Med. 2008 Dec 30; 27(30):6351-66. PMID: 18767204.
    Citations:    Fields:    Translation:Humans
  140. Takeuchi M. The significance of adaptive design in r&d in Japan. J Formos Med Assoc. 2008 Dec; 107(12 Suppl):9-13. PMID: 19129040.
    Citations:    Fields:    Translation:Humans
  141. Sasamura H, Nakaya H, Julius S, Takebayashi T, Sato Y, Uno H, Takeuchi M, Ishiguro K, Murakami M, Ryuzaki M, Itoh H. The short treatment with the angiotensin receptor blocker candesartan surveyed by telemedicine (STAR CAST) study: rationale and study design. Hypertens Res. 2008 Oct; 31(10):1843-9. PMID: 19015590.
    Citations: 2     Fields:    Translation:Humans
  142. Tsushima Y, Tateishi U, Uno H, Takeuchi M, Terauchi T, Goya T, Kim EE. Diagnostic performance of PET/CT in differentiation of malignant and benign non-solid solitary pulmonary nodules. Ann Nucl Med. 2008 Aug; 22(7):571-7. PMID: 18756359.
    Citations: 7     Fields:    Translation:Humans
  143. Yonemori K, Katsumata N, Noda A, Uno H, Yunokawa M, Nakano E, Kouno T, Shimizu C, Ando M, Tamura K, Takeuchi M, Fujiwara Y. Development and verification of a prediction model using serum tumor markers to predict the response to chemotherapy of patients with metastatic or recurrent breast cancer. J Cancer Res Clin Oncol. 2008 Nov; 134(11):1199-206. PMID: 18528707.
    Citations: 1     Fields:    Translation:HumansCTClinical Trials
  144. Abe D, Nakaseko C, Takeuchi M, Tanaka H, Ohwada C, Sakaida E, Takeda Y, Oda K, Ozawa S, Shimizu N, Masuda S, Cho R, Nishimura M, Misawa S, Kuwabara S, Saito Y. Restrictive usage of monoclonal immunoglobulin lambda light chain germline in POEMS syndrome. Blood. 2008 Aug 01; 112(3):836-9. PMID: 18497319.
    Citations: 6     Fields:    Translation:HumansCells
  145. Makino H, Haneda M, Babazono T, Moriya T, Ito S, Iwamoto Y, Kawamori R, Takeuchi M, Katayama S. Microalbuminuria reduction with telmisartan in normotensive and hypertensive Japanese patients with type 2 diabetes: a post-hoc analysis of The Incipient to Overt: Angiotensin II Blocker, Telmisartan, Investigation on Type 2 Diabetic Nephropathy (INNOVATION) study. Hypertens Res. 2008 Apr; 31(4):657-64. PMID: 18633177.
    Citations: 6     Fields:    Translation:Humans
  146. Saeki T, Sano M, Komoike Y, Sonoo H, Honjyo H, Ochiai K, Kobayashi T, Aogi K, Sato N, Sawai S, Miyoshi Y, Miyoshi Y, Takeuchi M, Takashima S. No increase of breast cancer incidence in Japanese women who received hormone replacement therapy: overview of a case-control study of breast cancer risk in Japan. Int J Clin Oncol. 2008 Feb; 13(1):8-11. PMID: 18307013.
    Citations: 5     Fields:    Translation:Humans
  147. Koizumi W, Narahara H, Hara T, Takagane A, Akiya T, Takagi M, Miyashita K, Nishizaki T, Kobayashi O, Takiyama W, Toh Y, Nagaie T, Takagi S, Yamamura Y, Yanaoka K, Orita H, Takeuchi M. S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial. Lancet Oncol. 2008 Mar; 9(3):215-21. PMID: 18282805.
    Citations: 546     Fields:    Translation:HumansCTClinical Trials
  148. Ohwada C, Nakaseko C, Koizumi M, Takeuchi M, Ozawa S, Naito M, Tanaka H, Oda K, Cho R, Nishimura M, Saito Y. CD44 and hyaluronan engagement promotes dexamethasone resistance in human myeloma cells. Eur J Haematol. 2008 Mar; 80(3):245-50. PMID: 18081709.
    Citations: 8     Fields:    Translation:HumansCells
  149. Yonemori K, Tateishi U, Uno H, Yonemori Y, Tsuta K, Takeuchi M, Matsuno Y, Fujiwara Y, Asamura H, Kusumoto M. Development and validation of diagnostic prediction model for solitary pulmonary nodules. Respirology. 2007 Nov; 12(6):856-62. PMID: 17986114.
    Citations: 14     Fields:    Translation:Humans
  150. Koizumi M, Nakaseko C, Ohwada C, Takeuchi M, Ozawa S, Shimizu N, Cho R, Nishimura M, Saito Y. Zoledronate has an antitumor effect and induces actin rearrangement in dexamethasone-resistant myeloma cells. Eur J Haematol. 2007 Nov; 79(5):382-91. PMID: 17903213.
    Citations: 7     Fields:    Translation:HumansCells
  151. Nakahara T, Kita A, Yamanaka K, Mori M, Amino N, Takeuchi M, Tominaga F, Hatakeyama S, Kinoyama I, Matsuhisa A, Kudoh M, Sasamata M. YM155, a novel small-molecule survivin suppressant, induces regression of established human hormone-refractory prostate tumor xenografts. Cancer Res. 2007 Sep 01; 67(17):8014-21. PMID: 17804712.
    Citations: 137     Fields:    Translation:HumansAnimalsCells
  152. Yonemori K, Yamaguchi U, Kaneko M, Uno H, Takeuchi M, Ando M, Fujiwara Y, Hosono A, Makimoto A, Hasegawa T, Yokoyama R, Nakatani F, Kawai A, Beppu Y, Chuman H. Prediction of response and prognostic factors for Ewing family of tumors in a low incidence population. J Cancer Res Clin Oncol. 2008 Mar; 134(3):389-95. PMID: 17687565.
    Citations: 4     Fields:    Translation:Humans
  153. Takeuchi M, Harigai M, Momohara S, Ball E, Abe J, Furuichi K, Kamatani N. Cloning and characterization of DPPL1 and DPPL2, representatives of a novel type of mammalian phosphatidate phosphatase. Gene. 2007 Sep 15; 399(2):174-80. PMID: 17590538.
    Citations: 6     Fields:    Translation:HumansCells
  154. Makino H, Haneda M, Babazono T, Moriya T, Ito S, Iwamoto Y, Kawamori R, Takeuchi M, Katayama S. Prevention of transition from incipient to overt nephropathy with telmisartan in patients with type 2 diabetes. Diabetes Care. 2007 Jun; 30(6):1577-8. PMID: 17389334.
    Citations: 56     Fields:    Translation:Humans
  155. Horie Y, Higaki J, Takeuchi M. Design, statistical analysis and sample size calculation of dose response study of telmisartan and hydrochlorothiazide. Contemp Clin Trials. 2007 Sep; 28(5):647-53. PMID: 17389151.
    Citations:    Fields:    Translation:Humans
  156. Momohara S, Okamoto H, Iwamoto T, Mizumura T, Ikari K, Kawaguchi Y, Takeuchi M, Kamatani N, Tomatsu T. High CCL18/PARC expression in articular cartilage and synovial tissue of patients with rheumatoid arthritis. J Rheumatol. 2007 Feb; 34(2):266-71. PMID: 17304652.
    Citations: 3     Fields:    Translation:Humans
  157. Yonemori K, Katsumata N, Kaneko M, Uno H, Matsumoto K, Kouno T, Shimizu C, Ando M, Takeuchi M, Fujiwara Y. Prediction of response to repeat utilization of anthracycline in recurrent breast cancer patients previously administered anthracycline-containing chemotherapeutic regimens as neoadjuvant or adjuvant chemotherapy. Breast Cancer Res Treat. 2007 Jul; 103(3):313-8. PMID: 17063267.
    Citations: 1     Fields:    Translation:Humans
  158. Nakaseko C, Sakaida E, Ohwada C, Ozawa S, Takeuchi M, Shimizu N, Cho R, Yokota A, Saito Y, Nishimura M. Acute fulminant myocarditis after allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning for acute myelogenous leukemia. Ann Hematol. 2007 Jan; 86(1):67-9. PMID: 17021838.
    Citations:    Fields:    Translation:Humans
  159. Tateishi U, Uno H, Yonemori K, Satake M, Takeuchi M, Arai Y. Prediction of lung adenocarcinoma without vessel invasion: a CT scan volumetric analysis. Chest. 2005 Nov; 128(5):3276-83. PMID: 16304272.
    Citations: 2     Fields:    Translation:Humans
  160. Takeuchi M, Akiyama R, Kobayashi S. Polymer-micelle incarcerated scandium as a polymer-supported catalyst for high-throughput organic synthesis. J Am Chem Soc. 2005 Sep 28; 127(38):13096-7. PMID: 16173708.
    Citations: 1     Fields:    Translation:Cells
  161. Yonemori K, Katsumata N, Uno H, Matsumoto K, Kouno T, Tokunaga S, Yamanaka Y, Shimizu C, Ando M, Takeuchi M, Fujiwara Y. Efficacy of weekly paclitaxel in patients with docetaxel-resistant metastatic breast cancer. Breast Cancer Res Treat. 2005 Feb; 89(3):237-41. PMID: 15754121.
    Citations: 9     Fields:    Translation:Humans
  162. Ohmori H, Oka M, Nishikawa Y, Shigemitsu H, Takeuchi M, Magari M, Kanayama N. Immunogenicity of autologous IgG bearing the inflammation-associated marker 3-nitrotyrosine. Immunol Lett. 2005 Jan 15; 96(1):47-54. PMID: 15585307.
    Citations: 5     Fields:    Translation:Animals
  163. Shimizu C, Hasegawa T, Tani Y, Takahashi F, Takeuchi M, Watanabe T, Ando M, Katsumata N, Fujiwara Y. Expression of insulin-like growth factor 1 receptor in primary breast cancer: immunohistochemical analysis. Hum Pathol. 2004 Dec; 35(12):1537-42. PMID: 15619214.
    Citations: 33     Fields:    Translation:Humans
  164. Momohara S, Okamoto H, Komiya K, Ikari K, Takeuchi M, Tomatsu T, Kamatani N. Matrix metalloproteinase 28/epilysin expression in cartilage from patients with rheumatoid arthritis and osteoarthritis: comment on the article by Kevorkian et al. Arthritis Rheum. 2004 Dec; 50(12):4074-5; author reply 4075. PMID: 15593191.
    Citations: 12     Fields:    Translation:Humans
  165. Mochizuki M, Hatsugaya M, Rokujoh E, Arita E, Hashiguchi M, Shimizu N, Takeuchi M, Yamamoto N, Akiba Y. [Randomized controlled study on the effectiveness of community pharmacists' advice for smoking cessation by Nicorette--evaluation at three months after initiation]. Yakugaku Zasshi. 2004 Dec; 124(12):989-95. PMID: 15577269.
    Citations:    Fields:    Translation:HumansCTClinical Trials
  166. Narukawa M, Yafune A, Takeuchi M. Observation of time-dependent adverse events and the influence of drop-out thereon in long-term safety studies--simulation study under the current practice of post-marketing safety evaluation in Japan. J Biopharm Stat. 2004 May; 14(2):403-14. PMID: 15206536.
    Citations:    Fields:    Translation:Humans
  167. Takeuchi M. The issues to be considered in global drug development. Control Clin Trials. 2002 Feb; 23(1):55-7. PMID: 11852165.
    Citations:    Fields:    Translation:Humans
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: SPH faculty should contact Faculty Affairs at facultyaffairshsph.harvard.edu).
Takeuchi's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (682)
Explore
_
Co-Authors (10)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.